Abacavir is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Avpak. The primary component is Abacavir Sulfate.
| Product ID | 50268-049_a2f05bba-8583-3c02-e053-2a95a90a65d1 |
| NDC | 50268-049 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Abacavir |
| Generic Name | Abacavir |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-04-10 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA091560 |
| Labeler Name | AvPAK |
| Substance Name | ABACAVIR SULFATE |
| Active Ingredient Strength | 300 mg/1 |
| Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-04-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA091560 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-04-10 |
| Marketing Category | ANDA |
| Application Number | ANDA091560 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-04-10 |
| Ingredient | Strength |
|---|---|
| ABACAVIR SULFATE | 300 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0121-0897 | Abacavir | Abacavir |
| 0904-6874 | Abacavir | Abacavir |
| 31722-557 | Abacavir | Abacavir |
| 31722-562 | Abacavir | Abacavir |
| 50268-049 | Abacavir | Abacavir |
| 64380-717 | Abacavir | Abacavir |
| 64980-405 | Abacavir | Abacavir Sulfate |
| 65862-073 | Abacavir | Abacavir |
| 65862-089 | Abacavir | Abacavir Sulfate |
| 68084-021 | Abacavir | Abacavir Sulfate |
| 69097-514 | Abacavir | Abacavir |
| 70518-0559 | Abacavir | Abacavir |
| 70518-1274 | Abacavir | Abacavir |
| 72865-167 | Abacavir | Abacavir |